GlassScriptPhysician profile
Amanda K Levine
NPI 1699756775
$3,760.87
in general payments reported to CMS, 2019-2025
39 companies · $459 in 2025
The $459 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $258 · 2021: $1,161 · 2022: $505 · 2023: $487 · 2024: $468 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,413.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $631.09 | 2019-2024 | |
| Astellas Pharma US INC | $385.23 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $352.32 | 2022-2025 | |
| Therapeuticsmd, INC. | $199.08 | 2019-2021 | |
| Pfizer INC. | $195.19 | 2021-2025 | |
| Gynesonics, INC. | $187.03 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.63 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $134.23 | 2023-2025 | Gemtesa, Myfembree |
| Avion Pharmaceuticals | $126.41 | 2019-2023 | Balcoltra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.71 | 2020-2022 | |
| Medtronic, INC. | $116.97 | 2024-2025 | Truclear, Interstim |
| Hologic Sales and Service, LLC | $95.33 | 2021-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Millicent US INC | $95.24 | 2023-2025 | Intrarosa, Femring |
| Coloplast Corp | $91.94 | 2021-2022 | |
| Evofem Biosciences, INC. | $88.52 | 2020-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $83.53 | 2019 | |
| Applied Medical Resources Corporation | $82.60 | 2025 | Gelpoint V-Path |
| Exeltis, USA INC. | $51.10 | 2021-2023 | Slynd |
| Merck Sharp & Dohme LLC | $48.02 | 2021-2023 | Gardasil 9 |
| Meditrina | $47.37 | 2023-2024 | |
| Allergan, INC. | $43.39 | 2019-2020 | |
| Axonics, INC. | $41.59 | 2020-2023 | Bulkamid |
| Scynexis, INC. | $41.44 | 2022 | |
| Myriad Women'S Health, INC. | $39.45 | 2023 | Myrisk |
| Lupin INC. | $30.40 | 2019 | |
| Minerva Surgical, INC | $28.21 | 2023-2025 | |
| Convatec INC. | $28.05 | 2025 | |
| Urovant Sciences INC | $27.80 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $27.36 | 2025 | |
| Innovation Technologies INC | $23.80 | 2025 | Irrisept |
| Abbott Laboratories | $22.83 | 2020 | |
| Galderma Laboratories, L.P. | $21.90 | 2020 | |
| Kerecis Limited | $19.36 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Mission Pharmacal Company | $16.71 | 2020 | |
| Agile Therapeutics, INC. | $16.67 | 2022 | |
| Boston Scientific Corporation | $15.73 | 2024 | Advantage System |
| Alydia Health | $15.65 | 2021 | |
| Sage Therapeutics, LLC | $13.45 | 2021 | |
| Acessa Health INC. | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.